Vitamin D3 Supplement Global Supply Chain Coverage
2,318개 기업
Vitamin D3 Supplement에 대해 수출업체 1,057개와 수입업체 1,261개가 매핑되어 있습니다.
수출업체와 수입업체는 Tridge 공급망 인텔리전스의 기업 프로필 및 분석을 활용해 Vitamin D3 Supplement 거래 상대를 식별하고, 시장 도달 범위를 벤치마킹하며, 시장별 아웃리치 우선순위를 정할 수 있습니다.
Vitamin D3 Supplement 수출 공급업체 인텔리전스, 무역 흐름 및 가격 시그널
Vitamin D3 Supplement에 대해 Tridge Supply Chain Intelligence에 수출업체 1,057개가 매핑되어 있습니다. 수출업체와 수입업체는 회사 프로필 및 분석을 활용해 공급업체 커버리지, 거래 활동, 경로 기회를 평가할 수 있습니다.
Vitamin D3 Supplement 상위 수출업체 및 공급업체 프로필
선도 수출업체 프로필을 검토하고 Vitamin D3 Supplement 공급망 인텔리전스 네트워크의 전체 수출업체 1,057개와 비교해 보세요. 수출업체와 수입업체는 회사 프로필 및 분석을 잠금 해제해 파트너를 더 빠르게 검증할 수 있습니다.
(인도)
최근 수출 거래: 2026-07-02
임직원 규모: 직원 51 - 100명
산업군: 식품 제조
밸류체인 역할: 식품 제조
수출 국가: 우즈베키스탄
공급 제품: Vitamin D Supplement, Vitamin D3 Supplement, Vitamin D3 Supplement (Liquid)
(콜롬비아)
최근 수출 거래: 2025-12-10
임직원 규모: 직원 101 - 500명
산업군: 식품 제조식품 포장기타
밸류체인 역할: 식품 제조기타
수출 국가: 페루
공급 제품: Vitamin D Supplement, Vitamin D3 Supplement, Vitamin D3 Supplement (Powder)
(덴마크)
최근 수출 거래: 2025-12-23
임직원 규모: 직원 101 - 500명
매출액: 매출 USD 10M - 50M
산업군: 식품 제조식품 포장기타
밸류체인 역할: 식품 제조기타
(미국)
최근 수출 거래: 2026-07-02
임직원 규모: 직원 51 - 100명
매출액: 매출 USD 10M - 50M
산업군: 기타
밸류체인 역할: 유통 / 도매
(인도)
최근 수출 거래: 2026-07-02
산업군: 식품 제조기타
밸류체인 역할: 식품 제조무역
(인도)
최근 수출 거래: 2026-07-02
임직원 규모: 직원 101 - 500명
산업군: 기타
밸류체인 역할: 유통 / 도매무역
수출 국가: 방글라데시
공급 제품: Vitamin D Supplement, Vitamin D3 Supplement, Vitamin D3 Supplement (Powder)
Vitamin D3 Supplement 글로벌 수출업체 커버리지
1,057개 기업
수출업체 수는 Vitamin D3 Supplement의 공급 깊이와 소싱 선택지의 핵심 신호입니다.
공급망 인텔리전스 분석을 활용해 Vitamin D3 Supplement 기회를 국가, 제품, 밸류체인 역할로 좁힌 뒤 기업 프로필을 열어 적합성을 검증하세요.
Vitamin D3 Supplement 수입 바이어 인텔리전스, 수요 시그널 및 가격 벤치마크
Vitamin D3 Supplement 수요 인텔리전스를 위해 수입업체 1,261개가 매핑되어 있습니다. Supply Chain Intelligence 회사 프로필 및 분석으로 시장별 바이어, 유통업체, 다운스트림 수요 파트너의 우선순위를 정하세요.
Vitamin D3 Supplement 상위 바이어, 수입업체 및 수요 파트너
선도 바이어 프로필을 검토하고 Vitamin D3 Supplement에 대해 추적되는 전체 수입업체 1,261개와 비교해 보세요. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석을 활용해 바이어 품질과 수요 집중도를 평가할 수 있습니다.
(스리랑카)
최근 수입 거래: 2026-01-04
산업군: 브로커 및 무역 대행기타
밸류체인 역할: 아랍에미리트
(우즈베키스탄)
최근 수입 거래: 2026-07-02
산업군: 기타
밸류체인 역할: -
(아제르바이잔)
최근 수입 거래: 2026-07-02
산업군: 식품 도매
밸류체인 역할: -
(카타르)
최근 수입 거래: 2026-07-02
임직원 규모: 직원 11 - 50명
산업군: 기타
밸류체인 역할: -
(네팔)
최근 수입 거래: 2025-12-03
산업군: 기타
밸류체인 역할: -
(네팔)
최근 수입 거래: 2026-07-02
산업군: 기타
밸류체인 역할: -
글로벌 수입업체 커버리지
1,261개 기업
수입업체 수는 Vitamin D3 Supplement에 대한 수요 측 가시성의 현재 깊이를 보여줍니다.
공급망 인텔리전스 분석과 기업 프로필을 활용해 활동 중인 Vitamin D3 Supplement 바이어를 식별하고, 국가별 파트너 밀도를 비교하며, GTM 우선순위를 정교화하세요.
Vitamin D3 (cholecalciferol) supplements are globally traded, finished “dose form” nutrition products sold as capsules, tablets, powders, and measured liquid solutions. Internationally, this category is shaped by regulatory regimes that may treat these products as foods/food supplements (e.g., Codex guideline scope and EU food supplement rules) and by manufacturing quality expectations (e.g., dietary supplement cGMP requirements in the United States). Product quality in trade is commonly anchored by pharmacopeial specifications for identity and potency of cholecalciferol and common dosage forms, alongside label-claim compliance. Product-specific trade quantification is often challenging because customs data typically tracks broader Harmonized System product groupings rather than “vitamin D3 supplements” as a single globally uniform line item.
Specification
Major VarietiesCholecalciferol (Vitamin D3)
Physical Attributes
Fat-soluble vitamin supplied as a concentrated nutrient in “dose forms” such as capsules, tablets, powders, and solutions (regulatory definitions in Codex guideline and EU food supplements directive).
Compositional Metrics
USP dietary supplement monograph: Cholecalciferol contains NLT 97.0% and NMT 103.0% of cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Tablets contain NLT 90.0% and NMT 115.0% of the labeled amount of cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Capsules contain NLT 90.0% and NMT 110.0% of the labeled amount of vitamin D as cholecalciferol.
USP dietary supplement monograph: Cholecalciferol Solution contains NLT 90.0% and NMT 120.0% of the labeled amount of vitamin D as cholecalciferol.
Grades
Pharmacopeial quality compliance (e.g., USP–NF dietary supplement monographs for cholecalciferol and relevant dosage forms) used as a specification anchor in some markets.
Packaging
Pre-packaged “dose form” presentations such as capsules, tablets/pills, powders in small-unit formats, and measured liquid forms (e.g., drop-dispensing bottles) are common in regulated markets.
ProcessingOil-based solutions and oil-filled capsule formats are common; USP recognizes cholecalciferol solutions in edible vegetable oil and certain solubilizing/solvent systems for solution dosage forms.
Supply Chain
Value Chain
Cholecalciferol ingredient sourcing → incoming component/label/packaging controls and identity testing → formulation (including oil-based solutions where applicable) → encapsulation/tableting → packaging & labeling → finished-product testing and release → holding & distribution under dietary supplement cGMP expectations (where applicable).
Demand Drivers
Used as a dietary supplement source of vitamin D (calciferol) to supplement dietary intake, including in products marketed as vitamin/mineral food supplements where regulated as foods.
Risks
Regulatory Compliance HighVitamin D3 supplements face high trade disruption risk from regulatory non-compliance (e.g., labeling, composition, and manufacturing control expectations). Jurisdictions vary in whether these products are regulated as foods/food supplements versus medicinal products, and enforcement actions (e.g., detentions, market withdrawals, recalls) can rapidly interrupt cross-border flows for non-compliant lots.Align formulation and labeling to destination-market rules; operate under appropriate GMP/cGMP systems; maintain robust identity/potency verification and documentation for components, packaging, labels, and finished lots.
Quality Variability MediumLabel-claim accuracy and potency conformance are central quality risks because vitamin D3 supplements are sold in concentrated dose forms and must meet stated labeled amounts. Pharmacopeial monographs specify acceptable assay ranges for cholecalciferol and common finished forms (tablets, capsules, solutions), and deviations can trigger rework, rejection, or compliance findings.Specify pharmacopeial-grade inputs where feasible; use validated assay methods and reference standards; implement batch-release testing to confirm labeled-amount conformance.
Trade Data Visibility MediumMarket intelligence and risk monitoring can be impaired because customs and trade databases classify products using Harmonized System groupings, and “vitamin D3 supplements” may be embedded within broader lines. This limits transparency on product-specific trade flows and can obscure sudden shifts in supplier or route concentration.Use a consistent HS scoping approach with product descriptions and ingredient identifiers; triangulate trade statistics with regulatory registrations and supplier qualification data.
FAQ
How is vitamin D3 typically sold in international supplement markets?Vitamin D3 supplements are commonly sold in pre-packaged “dose forms” such as capsules, tablets/pills, powders, and measured liquid solutions. This matches the product forms described in Codex guidance for vitamin/mineral food supplements and the EU definition of food supplements as dose-form products.
What standards are commonly used to define vitamin D3 supplement quality and potency?Pharmacopeial monographs are a common anchor for identity and potency expectations, and USP–NF includes dietary supplement monographs for cholecalciferol and for finished forms like tablets, capsules, and solutions. These monographs specify acceptable assay ranges around labeled amounts for those dosage forms.
What is the biggest compliance risk for vitamin D3 supplements in cross-border trade?The biggest risk is regulatory non-compliance, because food supplement rules and enforcement expectations differ by jurisdiction and can result in detentions, withdrawals, or recalls. Codex notes that its guideline applies where these products are regulated as foods, and major markets also impose manufacturing-control expectations such as dietary supplement cGMP requirements in the United States.